Mr. Ankit Banik is a PhD candidate at the Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Maharashtra. His doctoral research focuses on the development of novel and efficacious chimeric antigen receptor natural killer (CAR-NK) cell therapies, where he aims to harness the power of natural killer cells, a crucial component of the innate immune system, to target and eliminate cancer cells more effectively. His work aims to optimize the engineering of NK cells, enhancing their tumor-targeting capabilities and improving their overall therapeutic potential. His research strives to pave the way for innovative, personalized, and safer cancer treatments by advancing CAR-NK cell therapies.
Ankit completed his BSc in microbiology at University of Kalyani, acquiring a strong foundation in molecular biology, immunology, and cellular biology. Pursuing MSc in biotechnology at Pondicherry University, he honed his expertise in advanced laboratory techniques, genetic engineering, and cellular manipulation. Then as a project intern, he gained valuable research experience at the renowned Bose Institute.
As a Fulbright-Nehru Doctoral Research fellow, Ankit is exploring the potential of CAR-NK cell therapy that is more effective in targeting and treating solid tumors, overcoming the challenges posed by the tumor microenvironment and improving the therapeutic outcomes for patients. Ankit is committed to translating his findings into clinical applications that will benefit patients, and passionate about bridging the gap between laboratory research and real-world cancer therapies.
Ankit loves travelling and enjoys trekking and hiking. He has a strong appreciation of music and dance as well.